As promised, in Part Six of our Macular Degeneration educational series, Rule Eye Care has a big announcement!
Rule Eye Care Associates Offers Innovative Test to Detect Age-Related Macular Degeneration (AMD) in its Earliest Stages AdaptDx Testing in Lansing Office Can Help Prevent Blindness Caused by AMD
LANSING, MI, August 14, 2017– Rule Eye Care Associates, providers of the latest and best eye care technology since 1950, is the first private practice in Michigan to offer the AdaptDx® test to help detect and monitor age-related macular degeneration (AMD). AMD is the leading cause of irreversible vision loss in adults over age 50. The AdaptDx is a simple, non-invasive test that measures the time it takes a patient’s vision to adjust from bright light to darkness, a process known as dark adaptation. With the AdaptDx, optometrists at Rule Eye Care can diagnose AMD much earlier, allowing a plan to be put into place to help preserve vision.
“Age-related macular degeneration is a chronic disease that causes a part of your retina called the macula to slowly deteriorate as you get older. The macula is responsible for central vision, which allows you to do things like recognize faces, read, watch TV, and drive,” said Jeffrey Rule, OD. “With the AdaptDx, we are able to quickly and easily detect AMD in its earliest stages before the patient notices any impairment; and then monitor and treat the disease to provide the best care available.”
Dr. Jeffrey Rule, Dr Richard Rule, Dr. Brian Beissel, and Dr. Jeffrey Schrauben at Rule Eye Care recommend the AdaptDx screening test to patients over age 50, particularly those who have trouble seeing or driving at night. Risk factors for AMD include a family history of the disease, Caucasian race, smoking, obesity, high blood pressure, high cholesterol, or cardiovascular disease. “We are very excited to be one of the first practices to offer this state-of-the-art test to help identify AMD in its earliest stages and help our patients take action to preserve their vision,” said Dr. Rule. “While there is not a cure for AMD yet, there are several lifestyle changes and supplements that have a proven track record of delaying the progression of the disease.”
The AdaptDx test, which is performed in a darkened room, is non-invasive and easy to take. Nothing touches the patient’s eye and the test does not require pupil dilation. During the test, the patient looks into the AdaptDx and sees a flash of light, then watches for a series of dimmer lights and indicates when they are seen by clicking a button. The amount of time it takes to complete the test provides the doctor with vital information regarding the patient’s retinal function.
About Rule Eye Care Associates Since 1950, Rule Eye Care Associates has been providing comprehensive eye exams and quality vision care products to patients in Lansing, MI. Rule Eye Care strives to offer the absolute latest and best eye care technology that science can provide. They participate with most vision insurance plans including VSP and EYEMED, as well as accepting most major medical insurance plans, including Medicare, Blue Cross, SET, WEYCO and many others. Call 517.321.1154 to schedule an eye exam with one of our board-certified optometrists.
About AdaptDx® The AdaptDx is the only instrument that enables subclinical detection and management of age-related macular degeneration (AMD), the leading cause of adult blindness. This enables proactive treatment at each stage of this chronic disease to eliminate preventable blindness. Backed by more than 20 years of proven clinical research, the AdaptDx is an easy-to-use functional test that accurately measures dark adaptation, a key biomarker of AMD. The AdaptDx is made in the USA by MacuLogix, Inc. Visit www.MacuLogix.com for additional information. ... See MoreSee Less
On Monday, August 21, 2017, all of the United States will have a solar eclipse. The moon will cover at least part of the sun for 2 to 3 hours. Halfway through, anyone within a narrow path from Oregon ...